CN103069004B - 一种细胞染色体分析方法 - Google Patents
一种细胞染色体分析方法 Download PDFInfo
- Publication number
- CN103069004B CN103069004B CN201080068571.9A CN201080068571A CN103069004B CN 103069004 B CN103069004 B CN 103069004B CN 201080068571 A CN201080068571 A CN 201080068571A CN 103069004 B CN103069004 B CN 103069004B
- Authority
- CN
- China
- Prior art keywords
- chrn
- karyomit
- cell lines
- standard cell
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 210000000349 chromosome Anatomy 0.000 title claims abstract description 29
- 210000004027 cell Anatomy 0.000 claims abstract description 141
- 238000012163 sequencing technique Methods 0.000 claims abstract description 17
- 108020004414 DNA Proteins 0.000 claims description 40
- 210000001776 amniocyte Anatomy 0.000 claims description 39
- 230000002759 chromosomal effect Effects 0.000 claims description 38
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 29
- 238000004458 analytical method Methods 0.000 claims description 18
- 238000013467 fragmentation Methods 0.000 claims description 5
- 238000006062 fragmentation reaction Methods 0.000 claims description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 4
- 230000000873 masking effect Effects 0.000 claims description 3
- 210000004381 amniotic fluid Anatomy 0.000 abstract description 14
- 239000000523 sample Substances 0.000 description 92
- 208000036878 aneuploidy Diseases 0.000 description 13
- 231100001075 aneuploidy Toxicity 0.000 description 13
- 230000001605 fetal effect Effects 0.000 description 11
- 210000003754 fetus Anatomy 0.000 description 11
- 238000004113 cell culture Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 238000009826 distribution Methods 0.000 description 7
- 210000003765 sex chromosome Anatomy 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000007405 data analysis Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 201000010374 Down Syndrome Diseases 0.000 description 4
- 206010044688 Trisomy 21 Diseases 0.000 description 4
- 238000002669 amniocentesis Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000001766 X chromosome Anatomy 0.000 description 3
- 210000002593 Y chromosome Anatomy 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101100240528 Caenorhabditis elegans nhr-23 gene Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 201000006360 Edwards syndrome Diseases 0.000 description 2
- 201000009928 Patau syndrome Diseases 0.000 description 2
- 241000283907 Tragelaphus oryx Species 0.000 description 2
- 206010044686 Trisomy 13 Diseases 0.000 description 2
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 description 2
- 208000007159 Trisomy 18 Syndrome Diseases 0.000 description 2
- 208000026928 Turner syndrome Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012177 large-scale sequencing Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 201000003738 orofaciodigital syndrome VIII Diseases 0.000 description 2
- 238000003793 prenatal diagnosis Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010053884 trisomy 18 Diseases 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016852 Foetal damage Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 238000009609 prenatal screening Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N trimethylxanthine Natural products CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Description
序号 | Chr1% | Chr2% | Chr3% | Chr4% | Chr5% | Chr6% | Chr7% | Chr8% | Chr9% | Chr10% | Chr11% | Chr12% |
1 | 7.850 | 9.295 | 7.542 | 7.381 | 6.876 | 6.660 | 5.499 | 5.468 | 3.942 | 4.747 | 4.603 | 4.744 |
2 | 7.965 | 9.088 | 7.483 | 6.907 | 6.686 | 6.482 | 5.494 | 5.331 | 4.040 | 4.834 | 4.645 | 4.699 |
3 | 7.935 | 9.121 | 7.414 | 6.989 | 6.649 | 6.491 | 5.500 | 5.324 | 4.035 | 4.834 | 4.704 | 4.695 |
4 | 7.866 | 9.237 | 7.618 | 7.353 | 6.875 | 6.585 | 5.530 | 5.424 | 3.976 | 4.722 | 4.546 | 4.743 |
5 | 7.847 | 9.179 | 7.371 | 7.100 | 6.784 | 6.509 | 5.535 | 5.374 | 3.988 | 4.843 | 4.587 | 4.721 |
6 | 7.752 | 9.247 | 7.617 | 7.337 | 6.871 | 6.600 | 5.573 | 5.401 | 3.960 | 4.776 | 4.564 | 4.742 |
7 | 7.920 | 9.149 | 7.501 | 7.178 | 6.826 | 6.607 | 5.515 | 5.360 | 4.003 | 4.792 | 4.598 | 4.748 |
8 | 8.089 | 8.953 | 7.289 | 6.614 | 6.532 | 6.317 | 5.462 | 5.237 | 4.059 | 4.922 | 4.711 | 4.698 |
9 | 8.155 | 9.005 | 7.190 | 6.459 | 6.565 | 6.267 | 5.529 | 5.238 | 4.154 | 4.950 | 4.819 | 4.573 |
10 | 7.961 | 9.133 | 7.362 | 6.768 | 6.627 | 6.418 | 5.520 | 5.280 | 3.987 | 4.822 | 4.674 | 4.734 |
11 | 8.079 | 8.980 | 7.217 | 6.602 | 6.493 | 6.294 | 5.504 | 5.219 | 4.078 | 4.921 | 4.770 | 4.712 |
12 | 7.953 | 9.205 | 7.499 | 7.173 | 6.786 | 6.533 | 5.535 | 5.343 | 3.977 | 4.789 | 4.654 | 4.664 |
13 | 7.986 | 9.051 | 7.360 | 6.848 | 6.701 | 6.446 | 5.541 | 5.376 | 4.065 | 4.822 | 4.701 | 4.689 |
14 | 8.111 | 9.040 | 7.210 | 6.905 | 6.548 | 6.364 | 5.472 | 5.341 | 4.012 | 4.884 | 4.725 | 4.677 |
15 | 8.032 | 9.002 | 7.325 | 6.818 | 6.571 | 6.369 | 5.537 | 5.345 | 4.064 | 4.913 | 4.672 | 4.682 |
16 | 8.075 | 8.977 | 7.199 | 6.664 | 6.515 | 6.349 | 5.480 | 5.311 | 4.068 | 4.856 | 4.741 | 4.703 |
17 | 7.878 | 9.184 | 7.502 | 7.221 | 6.793 | 6.592 | 5.523 | 5.405 | 3.990 | 4.763 | 4.588 | 4.727 |
18 | 7.873 | 9.165 | 7.502 | 7.194 | 6.775 | 6.553 | 5.496 | 5.384 | 4.025 | 4.786 | 4.629 | 4.755 |
19 | 7.911 | 9.119 | 7.574 | 7.286 | 6.830 | 6.507 | 5.539 | 5.365 | 3.949 | 4.781 | 4.577 | 4.695 |
20 | 8.013 | 9.186 | 7.394 | 6.822 | 6.634 | 6.384 | 5.475 | 5.297 | 4.033 | 4.849 | 4.657 | 4.678 |
21 | 7.739 | 8.991 | 7.232 | 6.822 | 6.503 | 6.260 | 5.374 | 5.214 | 3.941 | 4.797 | 4.629 | 4.591 |
22 | 7.887 | 8.962 | 7.178 | 6.730 | 6.471 | 6.259 | 5.353 | 5.215 | 3.978 | 4.754 | 4.608 | 4.566 |
23 | 7.921 | 8.903 | 7.258 | 6.803 | 6.438 | 6.285 | 5.372 | 5.234 | 3.973 | 4.739 | 4.624 | 4.626 |
24 | 7.807 | 8.900 | 7.271 | 6.954 | 6.526 | 6.320 | 5.357 | 5.283 | 3.968 | 4.772 | 4.585 | 4.609 |
25 | 7.681 | 9.020 | 7.359 | 7.172 | 6.685 | 6.440 | 5.421 | 5.255 | 3.922 | 4.667 | 4.502 | 4.665 |
26 | 7.892 | 8.827 | 7.205 | 6.728 | 6.529 | 6.305 | 5.363 | 5.123 | 3.914 | 4.847 | 4.616 | 4.557 |
27 | 8.071 | 8.730 | 6.993 | 6.186 | 6.159 | 6.034 | 5.267 | 5.150 | 4.044 | 4.919 | 4.790 | 4.556 |
28 | 7.878 | 8.771 | 7.059 | 6.452 | 6.418 | 6.210 | 5.318 | 5.208 | 3.962 | 4.912 | 4.593 | 4.613 |
29 | 7.803 | 8.985 | 7.335 | 6.934 | 6.613 | 6.382 | 5.428 | 5.268 | 3.892 | 4.744 | 4.510 | 4.658 |
30 | 7.992 | 8.818 | 7.126 | 6.540 | 6.363 | 6.167 | 5.329 | 5.089 | 4.028 | 4.820 | 4.689 | 4.548 |
mean | 7.931 | 9.041 | 7.339 | 6.898 | 6.621 | 6.400 | 5.461 | 5.295 | 4.001 | 4.819 | 4.644 | 4.669 |
Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | |
Chr1% | 7.900099 | 7.781541 | 7.965013 | 7.937310 | 7.835625 | 7.756449 |
Chr2% | 9.195581 | 8.969471 | 8.998068 | 9.137041 | 8.836921 | 9.014913 |
Chr3% | 7.389485 | 7.365766 | 7.389563 | 7.452117 | 7.134356 | 7.378118 |
Chr4% | 7.090694 | 7.005976 | 6.921334 | 7.112517 | 6.510565 | 7.058824 |
Chr5% | 6.759707 | 6.600836 | 6.604984 | 6.768853 | 6.357255 | 6.605637 |
Chr6% | 6.541994 | 6.468799 | 6.461957 | 6.545516 | 6.170975 | 6.376054 |
Chr7% | 5.562187 | 5.423140 | 5.522745 | 5.521768 | 5.342112 | 5.403700 |
Chr8% | 5.387074 | 5.344078 | 5.357094 | 5.318220 | 5.176933 | 5.275211 |
Chr9% | 3.946516 | 3.924984 | 4.061791 | 4.037918 | 4.007161 | 3.958868 |
Chr10% | 4.831699 | 4.680082 | 4.876470 | 4.845395 | 4.798439 | 4.700673 |
Chr11% | 4.634992 | 4.541423 | 4.682686 | 4.637077 | 4.603257 | 4.462601 |
Chr12% | 4.727456 | 4.552861 | 4.734034 | 4.700509 | 4.571935 | 4.594756 |
Chr13% | 3.871131 | 3.749202 | 3.677764 | 3.875716 | 3.475357 | 3.776552 |
Chr14% | 3.261377 | 3.247342 | 3.285671 | 3.281681 | 3.238633 | 3.207609 |
Chr15% | 2.875226 | 2.782605 | 2.926826 | 2.866104 | 2.830466 | 2.757703 |
Chr16% | 2.516559 | 2.443884 | 2.624248 | 2.524383 | 2.665946 | 2.413713 |
Chr17% | 2.519897 | 2.481007 | 2.684055 | 2.561488 | 2.725292 | 2.495129 |
Chr18% | 3.026389 | 2.939323 | 3.027751 | 2.994205 | 2.893438 | 2.985936 |
Chr19% | 1.291162 | 1.240504 | 1.479644 | 1.317938 | 1.482326 | 1.235699 |
Chr20% | 2.096249 | 2.063225 | 2.174512 | 2.076472 | 2.173705 | 2.049467 |
Chr21% | 1.290966 | 1.267192 | 1.297270 | 1.291611 | 1.896099 | 1.297050 |
Chr22% | 0.992960 | 0.989674 | 1.125718 | 1.017386 | 1.164497 | 0.995698 |
ChrX% | 2.173990 | 4.134076 | 2.117655 | 2.177186 | 4.104752 | 4.197133 |
ChrY% | 0.116611 | 0.003010 | 0.003148 | 0.001590 | 0.003956 | 0.002508 |
Claims (24)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/001230 WO2012019323A1 (zh) | 2010-08-13 | 2010-08-13 | 一种细胞染色体分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103069004A CN103069004A (zh) | 2013-04-24 |
CN103069004B true CN103069004B (zh) | 2015-03-11 |
Family
ID=45567260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080068571.9A Active CN103069004B (zh) | 2010-08-13 | 2010-08-13 | 一种细胞染色体分析方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130210002A1 (zh) |
EP (1) | EP2604700B1 (zh) |
CN (1) | CN103069004B (zh) |
DK (1) | DK2604700T3 (zh) |
ES (1) | ES2552343T3 (zh) |
HK (1) | HK1185112A1 (zh) |
WO (1) | WO2012019323A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014153755A1 (zh) * | 2013-03-28 | 2014-10-02 | 深圳华大基因研究院 | 确定胎儿染色体非整倍性的方法、系统和计算机可读介质 |
CN108256296B (zh) * | 2017-12-29 | 2021-05-25 | 北京科迅生物技术有限公司 | 数据处理装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7659054B1 (en) * | 2000-05-23 | 2010-02-09 | Nuvelo, Inc. | Methods for genetic analysis of DNA to detect sequence variances |
US20030054386A1 (en) * | 2001-06-22 | 2003-03-20 | Stylianos Antonarakis | Method for detecting diseases caused by chromosomal imbalances |
CA2655272C (en) * | 2006-06-14 | 2017-04-18 | Living Microsystems, Inc. | Rare cell analysis using sample splitting and dna tags |
US20100015619A1 (en) * | 2006-10-30 | 2010-01-21 | Cytotrend (Beijing) Biotech Engineering Co., Ltd. | Method of detecting genomic aberrations for prenatal diagnosis |
PT2557517T (pt) * | 2007-07-23 | 2023-01-04 | Univ Hong Kong Chinese | Determinação de um desequilíbrio de sequências de ácido nucleico |
SI2334812T1 (sl) * | 2008-09-20 | 2017-05-31 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 | Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem |
US8574842B2 (en) * | 2009-12-22 | 2013-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Direct molecular diagnosis of fetal aneuploidy |
-
2010
- 2010-08-13 ES ES10855744.8T patent/ES2552343T3/es active Active
- 2010-08-13 US US13/640,691 patent/US20130210002A1/en not_active Abandoned
- 2010-08-13 EP EP10855744.8A patent/EP2604700B1/en active Active
- 2010-08-13 DK DK10855744.8T patent/DK2604700T3/en active
- 2010-08-13 CN CN201080068571.9A patent/CN103069004B/zh active Active
- 2010-08-13 WO PCT/CN2010/001230 patent/WO2012019323A1/zh active Application Filing
-
2013
- 2013-11-11 HK HK13112597.7A patent/HK1185112A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2552343T3 (es) | 2015-11-27 |
DK2604700T3 (en) | 2015-11-02 |
EP2604700B1 (en) | 2015-07-22 |
CN103069004A (zh) | 2013-04-24 |
EP2604700A1 (en) | 2013-06-19 |
HK1185112A1 (zh) | 2014-02-07 |
EP2604700A4 (en) | 2013-10-30 |
WO2012019323A1 (zh) | 2012-02-16 |
US20130210002A1 (en) | 2013-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103525939B (zh) | 无创检测胎儿染色体非整倍体的方法和系统 | |
CN103403183B (zh) | 胎儿遗传异常的无创性检测 | |
CN104232777B (zh) | 同时确定胎儿核酸含量和染色体非整倍性的方法及装置 | |
CN104169929B (zh) | 用于确定胎儿是否存在性染色体数目异常的系统和装置 | |
US20130130921A1 (en) | Kit, a Device and a Method for Detecting Copy Number of Fetal Chromosomes or Tumor Cell Chromosomes | |
CN102753703B (zh) | 胎儿染色体非整倍性的检测方法 | |
CN109072479A (zh) | 使用循环微粒对自发性早产风险进行分层 | |
CN104120181A (zh) | 对染色体测序结果进行gc校正的方法及装置 | |
CN104830986B (zh) | 一种检测胎儿基因信息的方法、装置和系统 | |
CN104156631B (zh) | 染色体三倍体检验方法 | |
CN105825076B (zh) | 消除常染色体内和染色体间gc偏好的方法及检测系统 | |
CN105483229A (zh) | 一种检测胎儿染色体非整倍体的方法及系统 | |
CN106537401A (zh) | 使用母体血清dna预测胎儿单基因遗传变异的方法 | |
CN104951671A (zh) | 基于单样本外周血检测胎儿染色体非整倍性的装置 | |
CN104520437B (zh) | 一种染色体非整倍性检测方法及装置 | |
CN105821117B (zh) | 多倍染色体检测用的标准品产品及其制备方法 | |
CN105039571A (zh) | 染色体非整倍体(t21、t18、t13)检测试剂盒的质控品及其应用 | |
CN103069004B (zh) | 一种细胞染色体分析方法 | |
WO2014019275A1 (en) | Noninvasive detection of fetal health status | |
CN105765076B (zh) | 一种染色体非整倍性检测方法及装置 | |
CN101928775A (zh) | 一种细胞染色体分析方法 | |
Lildballe et al. | Diagnostic performance of quantitative fluorescence PCR analysis in high-risk pregnancies after combined first-trimester screening | |
CN104178572B (zh) | 测序数据的处理方法及装置 | |
CN109321641B (zh) | 一种基于dna片段富集及测序技术的产前无创胎儿染色体检测系统 | |
CN110438216B (zh) | 一种用于性别鉴定的基因试剂盒及21号染色体综合症辅助鉴定用试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN BEIJING GENOMICS INSTITUTE HEALTH TECHNOL Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20130923 Free format text: FORMER OWNER: BGI-SHENZHEN Effective date: 20130923 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130923 Address after: 518083 science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, 9F-7, 8, Shenzhen Applicant after: Shenzhen Huada Gene Health Technology Co., Ltd. Address before: North Road No. 146, building 11F-3 Industrial Zone in Yantian District of Shenzhen city of Guangdong Province in 518083 Applicant before: BGI-Shenzhen Co., Ltd. Applicant before: BGI-Shenzhen |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 518083 science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, 9F-7, 8, Shenzhen Applicant after: Shenzhen BGI Medicine Co., Ltd. Address before: 518083 science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, 9F-7, 8, Shenzhen Applicant before: Shenzhen Huada Gene Health Technology Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHENZHEN BEIJING GENOMICS INSTITUTE HEALTH TECHNOLOGY CO., LTD. TO: SHENZHEN BGI MEDICINE CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHENZHEN BGI CORPORATION Free format text: FORMER NAME: SHENZHEN BGI MEDICINE CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Patentee after: BGI SHENZHEN CO LTD Address before: 518083 science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, 9F-7, 8, Shenzhen Patentee before: Shenzhen BGI Medicine Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160714 Address after: Beishan Industrial Zone Building in Yantian District of Shenzhen city in Guangdong province 518083 1, 9, 3 and 11 floor of Building 1, 5 floor Patentee after: Shenzhen Huada clinical inspection center Co., Ltd. Address before: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Patentee before: BGI SHENZHEN CO LTD |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 518083 1st, 3rd, 4th and 5th floors of 11 buildings in Beishan Industrial Zone, Yantian Street, Yantian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Huada clinical laboratory center Address before: 518083 Shenzhen Yantian Beishan Industrial Zone Complex Building 1, 9 Floors and 11 1, 3, 5 Floors Patentee before: Shenzhen Huada clinical inspection center Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 518083 1st, 3rd, 4th and 5th floors of 11 buildings in Beishan Industrial Zone, Yantian Street, Yantian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Huada Medical Laboratory Address before: 518083 1st, 3rd, 4th and 5th floors of 11 buildings in Beishan Industrial Zone, Yantian Street, Yantian District, Shenzhen City, Guangdong Province Patentee before: SHENZHEN HUADA CLINIC EXAMINATION CENTER |